Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Kidney Int. 2013 Mar;83(3):455-62. doi: 10.1038/ki.2012.382. Epub 2012 Dec 19.
IgG4-related disease (IgG4-RD) is a systemic immune-mediated disease that typically manifests as fibro-inflammatory masses that can affect nearly any organ system. Renal involvement by IgG4-RD usually takes the form of IgG4-related tubulointerstitial nephritis, but cases of membranous glomerulonephritis (MGN) have also been described. Here we present a series of 9 patients (mean age at diagnosis 58 years) with MGN associated with IgG4-RD. All patients showed MGN on biopsy, presented with proteinuria (mean 8.3 g/day), and most had elevated serum creatinine (mean 2.2 mg/dl). Seven patients had known extrarenal involvement by IgG4-RD, with 5 patients having concurrent IgG4-related tubulointerstitial nephritis. Immunohistochemical analysis for the phospholipase A2 receptor, a marker of primary MGN, was negative in all 8 biopsies so examined. Six of 7 patients with available follow-up (mean 39 months) were treated with immunosuppressive agents; one untreated patient developed end-stage renal disease and underwent transplantation, without recurrence at 12 years after transplant. All 6 treated patients showed decreased proteinuria (mean 1.2 g/day), and most showed decreased serum creatinine (mean 1.4 mg/dl). Thus, MGN should be included in the spectrum of IgG4-RD and should be suspected in proteinuric IgG4-RD patients. Conversely, patients with MGN and an appropriate clinical history should be evaluated for IgG4-RD.
IgG4 相关疾病(IgG4-RD)是一种系统性免疫介导的疾病,通常表现为纤维炎症性肿块,可影响几乎任何器官系统。IgG4-RD 累及肾脏通常表现为 IgG4 相关的肾小管间质性肾炎,但也有膜性肾小球肾炎(MGN)的病例报道。在这里,我们介绍了一组 9 例 MGN 合并 IgG4-RD 的患者(诊断时的平均年龄为 58 岁)。所有患者的活检均显示 MGN,表现为蛋白尿(平均 8.3g/天),大多数患者的血清肌酐升高(平均 2.2mg/dl)。7 例患者有已知的 IgG4-RD 肾外受累,5 例患者同时伴有 IgG4 相关的肾小管间质性肾炎。对 8 例进行了检查的活检标本进行了磷脂酶 A2 受体的免疫组织化学分析,该受体是原发性 MGN 的标志物,结果均为阴性。6 例有随访资料的患者(平均 39 个月)接受了免疫抑制治疗;1 例未治疗的患者发展为终末期肾病并接受了移植,移植后 12 年未复发。所有 6 例接受治疗的患者蛋白尿减少(平均 1.2g/天),大多数患者血清肌酐减少(平均 1.4mg/dl)。因此,MGN 应包括在 IgG4-RD 的谱中,并应在蛋白尿 IgG4-RD 患者中怀疑该病。相反,有 MGN 和适当临床病史的患者应评估 IgG4-RD。